Dillons Pharmacy Springfield
Dexmedetomidine for use as adjunct therapy in Alcohol Withdrawal Syndrome (AWS) and Delirium Tremens (DT)
Kyle Dillon, PharmD
PGY-1 Pharmacy Resident
HSHS St. John's Hospital
5:00 pm - Registration
6:00 pm - Program
7:00 pm - Dinner (on your own)
Please register below. Registration deadline is Thursday, March 9th.
There is no fee for ICHP members to attend this activity. Non-members will be charged $20 at the time of registration. Participants will be required to sign in at the start of the program.
Fire and Ale
135 Illini Blvd
Sherman, IL 62684
Please register for this event so that the appropriate number of wait staff will be present.
At the conclusion of this knowledge-based continuing pharmacy education activity, pharmacist participants should be able to:
1. Identify the patients at risk for alcohol withdrawal syndrome (AWS) and delirium tremens (DT).
2. Discuss the 2004 American Society of Addiction Medicine guideline for Management of Alcohol Withdrawal Delirium.
3. Review the primary literature for the use of dexmedetomidine as adjunct therapy for treatment of AWS and DT.
4. Explain the advantages and disadvantages of dexmedetomidine as adjunct therapy for patients with AWS and DT in clinical practice.
At the conclusion of this knowledge-based continuing pharmacy education activity, pharmacy technician participants should be able to:
1. Recognize the common signs and symptoms of alcohol withdrawal syndrome (AWS) and delirium tremens (DT).
2. Identify the different classes of medications used to treat AWS and DT.
3. Explain the benefit of dexmedetomidine for treatment of patients with AWS and DT.
1.0 Contact Hour (0.1 CEU) Type of Activity: Knowledge-based
The Illinois Council of Health System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity provides 1 hour (0.1 CEU) of continuing pharmacy education credit (ACPE Activity # 0121-0000-17-015-L01-P & 0121-0000-17-015-L01-T).
Attendees must complete a program evaluation and CPE submission online at . After successful CPE submission to CPE Monitor, attendees may print their statements of continuing pharmacy education credit at .
Target Audience: This knowledge-based activity was developed for Health-System Pharmacists and Pharmacy Techncians.
PTCB requires CPhTs to submit 20 hours of pharmacy technician-specific (‘T-specific’) continuing pharmacy education (CPE) to qualify for recertification. Pharmacy technicians will no long be able to use Pharmacist only or P-specific CPE. In addition, PTCB reduced the number of allowable CPE hours earned through in-service training from 10 to 5. Please advise all pharmacy technicians at your site of this change. As an ACPE accredited provider, ICHP will continue to include Technician specific programming in most if not all of our CPE programming.
CPE Monitor: When registering for this program, you will be required to provide your NABP eProfile ID# and Birthday (MMDD) when registering for this meeting. This information will be required by any participants seeking CPE credit.